SCHEMBL8579232

SCHEMBL8579232

CC(C)(C)c1cc(C=C(S)C(=O)O)cc(C(C)(C)C)c1O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABBR2 O75899 2/20 0.57
GABBR1 Q9UBS5 2/20 0.57
MEN1 O00255 3/20 0.51
CYP3A4 P08684 3/20 0.51
MAPT P10636 3/20 0.51
TSHR P16473 3/20 0.51
BLM P54132 3/20 0.51
KMT2A Q03164 3/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
HSD17B10 Q99714 3/20 0.51
CYP1A2 P05177 3/20 0.51
CYP2C9 P11712 3/20 0.51
RGS12 O14924 2/20 0.51
GMNN O75496 2/20 0.51
ALDH1A1 P00352 2/20 0.51
LMNA P02545 2/20 0.51
TP53 P04637 2/20 0.51
HPGD P15428 2/20 0.51
ALOX15 P16050 2/20 0.51
NFKB1 P19838 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8579230 1.00 GABBR2 (0.57) GABBR2GABBR1MEN1CYP3A4MAPT
SCHEMBL6937644 0.82 GABBR2 (0.60) GABBR2GABBR1MEN1CYP3A4MAPT
SCHEMBL7824832 0.82 GABBR2 (0.60) GABBR2GABBR1MEN1CYP3A4MAPT
SCHEMBL11303373 0.81 GABBR2 (0.58) GABBR2GABBR1MEN1CYP3A4MAPT
SCHEMBL11303376 0.81 GABBR2 (0.58) GABBR2GABBR1MEN1CYP3A4MAPT
SCHEMBL9684949 0.78 GABBR2 (0.55) GABBR2GABBR1MEN1CYP3A4MAPT
SCHEMBL9580152 0.78 GABBR2 (0.55) GABBR2GABBR1MEN1CYP3A4MAPT
SCHEMBL10494818 0.77 GABBR2 (0.54) GABBR2GABBR1MEN1CYP3A4MAPT
SCHEMBL10967937 0.77 GABBR2 (0.54) GABBR2GABBR1MEN1CYP3A4MAPT
SCHEMBL28419449 0.76 EGFR (0.63) GABBR2GABBR1MEN1CYP3A4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5731336-A USING ARYL-SUBSTITUTED RHODAMINES ELI LILLY AND COMPANY (US) 1998-03-24 US disclosed
US-5691367-A ANTIINFLAMMATORY AGENTS OR ANTIARTHRITIC AGENTS ELI LILLY AND COMPANY (US) 1997-11-25 US disclosed
EP-0722729-A2 Aryl-substituted rhodanines for treating multiple sclerosis ELI LILLY AND COMPANY (US) 1996-07-24 EP disclosed
EP-0391644-B1 Aryl-substituted rhodanine derivatives LILLY CO ELI (US) 1996-06-19 EP disclosed
US-5356917-A Antiischemic, antiinflammatory, antiarthritic agents, treat-ment of dystrophic mammals ELI LILLY AND COMPANY (US) 1994-10-18 US disclosed
US-5158966-A Aryl-substituted rhodanine derivatives THE UNIVERSITY OF COLORADO FOUNDATION, INC. (US) 1992-10-27 US disclosed
EP-0500337-A1 Composition containing aryl-substituted rhodanine derivatives for the treatment of type I diabetes UNIVERSITY OF COLORADO FOUNDATION, INC. (US) 1992-08-26 EP disclosed
EP-0391644-A2 Aryl-substituted rhodanine derivatives ELI LILLY AND COMPANY (US) 1990-10-10 EP disclosed
EP-0211670-B1 DI-T-BUTYLPHENOL COMPOUNDS ELI LILLY AND COMPANY (US) 1990-05-09 EP disclosed
EP-0211670-A2 Di-t-butylphenol compounds ELI LILLY AND COMPANY (US) 1987-02-25 EP disclosed